Merck Sharp & Dohme LLC is recalling 848 kits of Emend (aprepitant) and Noxafil Powdermix (posaconazole) oral suspensions because they may contain metal particles. This voluntary recall affects 3 kits of Emend and 845 kits of Noxafil distributed nationwide. Consumers who have these medications should check their lot numbers and contact their healthcare provider or pharmacist.
The presence of metal particulates in an oral medication poses a potential risk of irritation or injury to the digestive tract. If the particles are small enough to be absorbed or if the product is administered through a feeding tube, they could cause more serious internal complications or mechanical blockages.
You have 2 options:
Manufactured by Novo Nordisk Production Ireland Limited
Manufactured by N.V. Organon
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.